|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
1 Institute for Bioinorganic and Radiopharmaceutical Chemistry, Research Center Rossendorf, Dresden, Germany
2 Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus, Dresden, Germany
3 Leibniz Institute of Polymer Research Dresden, Dresden, Germany
* To whom correspondence should be addressed. E-mail: martin.bornhaeuser{at}uniklinikum-dresden.de.
| Abstract |
|---|
CD34+ hematopoietic stem/progenitor cells (HSC) reside in the bone marrow in close vincinity to the endosteal bone surface, surrounded by osteoblasts, stromal cells and various extracellular matrix molecules. We utilized a bioartificial matrix of fibrillar collagen I, the major matrix component of bone, as scaffold for ex vivo expansion of HSCs. CD34+ HSCs were isolated from umbilical cord blood and cultivated within reconstituted collagen I fibrils in presence of FLT3-ligand, SCF and IL-3. After seven days of culture cell number, colony-forming units and gene expression profile of the cultured cells were assessed. Although the total expansion factor of CD34+ cells was slightly lower when cells were cultivated in the collagen I gel, the frequency of colony-forming cells (CFU-C) increased compared to control suspension cultures. Gene expression analysis with mircoarray chip technology revealed the upregulation of more than 50 genes in presence of collagen I. Among them, genes for several growth factors, cytokines and chemokines (e.g. interleukin 8, MIP1-
) could be confirmed by quantitative PCR. Furthermore, increased expression of the negative cell-cycle regulator BTG2/TIS21 and an inhibitor of MAP kinase pathway, DUSP2, underline the regulatory role of the extracellular matrix. Together, these data show that the expansion of CD34+ cord blood cells in a culture system containing a three-dimensional collagen I matrix induces a qualitative change in the gene expression profile of cultivated HSCs.
This article has been cited by other articles:
![]() |
X. Yang, M. Morita, H. Wang, T. Suzuki, W. Yang, Y. Luo, C. Zhao, Y. Yu, M. Bartlam, T. Yamamoto, et al. Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity Nucleic Acids Res., December 1, 2008; 36(21): 6872 - 6881. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhou, A. N. Nguyen, D. Sohal, J. Ying Ma, P. Pahanish, K. Gundabolu, J. Hayman, A. Chubak, Y. Mo, T. D. Bhagat, et al. Inhibition of the TGF-{beta} receptor I kinase promotes hematopoiesis in MDS Blood, October 15, 2008; 112(8): 3434 - 3443. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Kim, M. S. Ryu, S. P. Oh, and I. K. Lim TIS21/BTG2 Negatively Regulates Estradiol-Stimulated Expansion of Hematopoietic Stem Cells by Derepressing Akt Phosphorylation and Inhibiting mTOR Signal Transduction Stem Cells, September 1, 2008; 26(9): 2339 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Graham, J. K. Vass, T. L. Holyoake, and G. J. Graham Transcriptional Analysis of Quiescent and Proliferating CD34+ Human Hemopoietic Cells from Normal and Chronic Myeloid Leukemia Sources Stem Cells, December 1, 2007; 25(12): 3111 - 3120. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
